Trinity Biotech PLC (TRIB)
1.30
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
1.30
0.00 (0.00%)
After-Hours: 07:40
Trinity Biotech Gross Profit Margin (Quarterly): 35.03% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 35.03% |
| June 30, 2024 | 36.19% |
| March 31, 2024 | 37.55% |
| December 31, 2023 | 34.01% |
| September 30, 2023 | 29.16% |
| June 30, 2023 | 36.19% |
| March 31, 2023 | 37.58% |
| December 31, 2022 | 34.18% |
| September 30, 2022 | 2.10% |
| June 30, 2022 | 36.20% |
| March 31, 2022 | 38.16% |
| December 31, 2021 | 33.91% |
| September 30, 2021 | 40.45% |
| June 30, 2021 | 42.67% |
| March 31, 2021 | 42.64% |
| December 31, 2020 | 47.79% |
| September 30, 2020 | 52.40% |
| June 30, 2020 | 42.88% |
| March 31, 2020 | 43.80% |
| December 31, 2019 | 43.50% |
| September 30, 2019 | 40.95% |
| June 30, 2019 | 41.95% |
| March 31, 2019 | 42.40% |
| December 31, 2018 | 41.73% |
| September 30, 2018 | 42.09% |
| Date | Value |
|---|---|
| June 30, 2018 | 43.23% |
| March 31, 2018 | 43.82% |
| December 31, 2017 | 41.51% |
| September 30, 2017 | 42.95% |
| June 30, 2017 | 42.51% |
| March 31, 2017 | 42.02% |
| December 31, 2016 | 40.03% |
| September 30, 2016 | 44.66% |
| June 30, 2016 | 44.95% |
| March 31, 2016 | 43.08% |
| December 31, 2015 | 43.18% |
| September 30, 2015 | 46.52% |
| June 30, 2015 | 46.97% |
| March 31, 2015 | 47.94% |
| December 31, 2014 | 43.83% |
| September 30, 2014 | 47.90% |
| June 30, 2014 | 48.10% |
| March 31, 2014 | 48.60% |
| December 31, 2013 | 49.61% |
| September 30, 2013 | 49.66% |
| June 30, 2013 | 49.02% |
| March 31, 2013 | 50.01% |
| December 31, 2012 | 50.59% |
| September 30, 2012 | 51.02% |
| June 30, 2012 | 51.60% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
2.10%
Minimum
Sep 2022
52.40%
Maximum
Sep 2020
37.32%
Average
37.57%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Amarin Corp PLC | 38.48% |
| DBV Technologies SA | -- |
| Ascendis Pharma AS | 80.63% |
| Cellectis SA | -- |
| Adaptimmune Therapeutics PLC | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -25.10% |
| Return on Invested Capital | -45.03% |
| Profit Margin (Quarterly) | -31.41% |
| Operating Margin (Quarterly) | -14.64% |
| Return on Net Operating Assets | -27.11% |